The leading Japanese medical VR company Jolly Good Inc. has recently established a specialized DTx Division to develop digital therapeutics (below, “DTx”) using VR and AI technologies.

Dr. Ayako Kanie and Dr. Aiichiro Nakajima, psychiatrists and leaders in the development of cognitive behavioral therapy at top research institutes in Japan, will officially participate with Jolly Good.
Jolly Good has been developing social skills training VR for developmental disabilities and digital therapeutics VR for depression.

After agreeing that Jolly Good’s high-quality VR could be effective for mental illness, both doctors made the decision to participate.

VRDTx